TANDEM DIABETES CARE INC

NASDAQ: TNDM (Tandem Diabetes Care, Inc.)

Kemas kini terakhir: 32 minit lalu

16.56

-0.49 (-2.87%)

Penutupan Terdahulu 17.05
Jumlah Dagangan 1,220,578
Harga / Pendapatan (P/E Ke hadapan) 189.56
Harga / Jualan (P/S) 1.09
Harga / Buku (P/B) 8.81
Julat 52 Minggu
12.26 (-25%) — 29.65 (79%)
Margin Keuntungan -18.71%
Margin Operasi (TTM) -14.71%
EPS Cair (TTM) -2.79
Pertumbuhan Hasil Suku Tahunan (YOY) 22.30%
Jumlah Hutang/Ekuiti (D/E MRQ) 320.75%
Nisbah Semasa (MRQ) 2.30
Aliran Tunai Operasi (OCF TTM) 13.94 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 67.48 M
Pulangan Atas Aset (ROA TTM) -6.17%
Pulangan Atas Ekuiti (ROE TTM) -92.31%

AISkor Stockmoo

-1.4
Pulangan di bawah kos modalnya. Pulangan atas modal menurun. info
Hutang tinggi. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai positif. info
Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info NA
Penilaian Relatif info NA
Pertumbuhan Tersirat info NA
Sejarah Penilaian info NA
Nilai Pegangan info NA
Premium Risiko info NA
Penilaian Pasaran info NA
Tiada aliran jelas sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info
Aliran menurun, tetapi purata bergeraknya telah mendatar. info
Daripada analisis teknikal AI kami terhadap carta. info NA
Corak Lilin info NA
Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info
Berita terkini kebanyakannya positif. info
Sentimen Pegangan info NA
Beberapa orang dalam menjual bersih baru-baru ini. info
Institusi bersih +8.37% daripada saham dalam pemfailan 13F terkini: 140 pemegang menambah, 137 mengurang (suku berakhir 30 Sep 2026). info
Kedudukan jual singkat +37.6% dari 31 Aug hingga 30 Oct 2026, 7.6 hari untuk tutup (FINRA). info
Persekitaran pasaran berhati-hati. info
Sektor ketinggalan berbanding pasaran.
Tonggak-tonggak sependapat, jadi skor diperkukuh.
Hampir dengan garis aliran jangka sederhana. info
Harga rendah berbanding purata 52 minggunya. Turun dalam tempoh 5 tahun. info
Momentum jangka pendek menurun. info
Harga hampir dengan paras sokongan. info
Skor Akhir -1.36
Tunjuk semua

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Devices (US) Bercampur Bercampur
Medical Devices (Global) Bercampur Bercampur
Stok Tandem Diabetes Care, Inc. Bercampur Menaik

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B Skor
TNDM - - - 8.81 -1.4
BWAY - - - 4.62 0.4
SSII - - - 6.11 -2.0
QTI - - - 9.14 -5.0
AXGN - - - 6.12 0.0
ESTA - - - 128.59 -1.7

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Sektor Healthcare
Industri Medical Devices
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 0.95%
% Dimiliki oleh Institusi 110.87%

Pemilikan

Nama Tarikh Syer Dipegang
First Light Asset Management, Llc 30 Sep 2026 3,251,835
Gw&K Investment Management, Llc 30 Sep 2026 2,903,529
Longaeva Partners L.P. 30 Sep 2026 2,358,636
Ubs Group Ag 30 Sep 2026 2,196,689
Exoduspoint Capital Management, Lp 30 Sep 2026 2,079,371
Millennium Management Llc 30 Sep 2026 2,070,772
Paradice Investment Management Llc 30 Sep 2026 2,007,415
Jennison Associates Llc 30 Sep 2026 1,903,283
Jacobs Levy Equity Management, Inc 30 Sep 2026 1,890,510

Tiada data dalam julat masa ini.

Nama Purata Belian ($) Purata Jualan ($) Jumlah Net Jumlah Nilai Bersih ($)
BEAVER SANDRA - - 0 0
CARPENTER RICK - 20.07 -1,276 -25,609
GASSER ELIZABETH ANNE - 20.07 -1,618 -32,473
HANSEN SHANNON MARIE - 20.07 -1,535 -30,807
KYRILLOS JEAN-CLAUDE 18.48 20.07 -328 -6,912
MORRISON SUSAN - 20.07 -810 -16,257
SHERIDAN JOHN F - 20.07 -8,100 -162,567
VOSSELLER LEIGH - 20.07 -1,479 -29,684
Jumlah Keseluruhan Kuantiti Bersih -15,146
Jumlah Keseluruhan Nilai Bersih ($) -304,309
Purata Pembelian Keseluruhan ($) 18.48
Purata Jualan Keseluruhan ($) 20.07
Julat Insider ($)
18.48 (11%) — 20.07 (21%)
Nama Pemegang Tarikh Jenis Kuantiti Harga Nilai ($)
KYRILLOS JEAN-CLAUDE Pegawai 16 Nov 2026 Diperolehi (+) 207 18.48 3,825
BEAVER SANDRA Pengarah 15 Nov 2026 Pelaksanaan pilihan 6,747 - -
CARPENTER RICK Pegawai 15 Nov 2026 Dibuang (-) 1,276 20.07 25,609
CARPENTER RICK Pegawai 15 Nov 2026 Pelaksanaan pilihan 2,506 - -
GASSER ELIZABETH ANNE Pegawai 15 Nov 2026 Dibuang (-) 1,618 20.07 32,473
GASSER ELIZABETH ANNE Pegawai 15 Nov 2026 Pelaksanaan pilihan 3,014 - -
HANSEN SHANNON MARIE Pegawai 15 Nov 2026 Dibuang (-) 1,535 20.07 30,807
HANSEN SHANNON MARIE Pegawai 15 Nov 2026 Pelaksanaan pilihan 3,014 - -
KYRILLOS JEAN-CLAUDE Pegawai 15 Nov 2026 Dibuang (-) 535 20.07 10,737
KYRILLOS JEAN-CLAUDE Pegawai 15 Nov 2026 Pelaksanaan pilihan 1,009 - -
MORRISON SUSAN Pegawai 15 Nov 2026 Dibuang (-) 810 20.07 16,257
MORRISON SUSAN Pegawai 15 Nov 2026 Pelaksanaan pilihan 2,828 - -
SHERIDAN JOHN F Pengarah 15 Nov 2026 Dibuang (-) 8,100 20.07 162,567
SHERIDAN JOHN F Pengarah 15 Nov 2026 Pelaksanaan pilihan 15,917 - -
VOSSELLER LEIGH Pegawai 15 Nov 2026 Dibuang (-) 1,479 20.07 29,684
VOSSELLER LEIGH Pegawai 15 Nov 2026 Pelaksanaan pilihan 4,119 - -
Papar semua

Institusi

Pemilikan institusi: 128.77%

Kedudukan Pemegang Saham
Bertambah 140 17,373,437
Berkurang 137 14,384,953
Baharu 42 6,940,860
Dijual habis 46 4,068,138

Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.

Kedudukan Jual Singkat

Penyelesaian Saham Hari untuk tutup
30 Oct 2026 16,171,009 7.6
15 Oct 2026 15,086,560 6.9
30 Sep 2026 13,369,091 5.2
15 Sep 2026 12,474,385 7.9
31 Aug 2026 11,753,819 8.2
14 Aug 2026 10,585,732 3.9

Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.

9 Positif 0 Negatif 6 Neutral
Tarikh Jenis Butiran
18 Nov 2026 Yahoo Finance Tandem Diabetes shares climb 5% after Stifel upgrades stock to Buy
Investing.com -- Shares of Tandem Diabetes Care Inc (NASDAQ:TNDM) climbed 5.1% in premarket trading on Wednesday after Stifel upgraded the medical device maker to Buy from Hold, pointing to an improving margin trajectory and upcoming product catalysts. Analyst Jonathan Block also lifted his price…
18 Nov 2026 Yahoo Finance Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls
Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls…
16 Nov 2026 Yahoo Finance Tandem wins FDA clearance for tubeless automated insulin delivery system
The clearance tees up a 2027 launch of a product that analysts called Tandem’s “single most important commercial catalyst and growth driver.”
13 Nov 2026 Yahoo Finance Tandem Diabetes stock jumps 8% on FDA clearance for tubeless pump
Investing.com -- Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) rose 8% after the company announced U.S. Food and Drug Administration clearance for its Tandem Mobi insulin pump to operate as a tubeless automated insulin delivery system with up to seven days of wear.
13 Nov 2026 Yahoo Finance Tandem Mobi Now FDA Cleared as World’s First and Only Tubeless AID System with up to Seven Days of Wear
SAN DIEGO, November 13, 2026--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of Tandem Mobi for use as the world’s first and only tubeless automated insulin delivery system with…
13 Nov 2026 Yahoo Finance Can Tandem Diabetes Care (TNDM) Stay Cheap After Its Recall?
Tandem Diabetes Care has been through a bruising stretch, with the share price down about 87.2% over the past five years, and yet the business still commands meaningful attention in insulin pump therapy. With that kind of long term decline and fresh headlines around its devices, the question now is…
12 Nov 2026 Yahoo Finance Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump
SAN DIEGO, November 12, 2026--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of Health Canada approval of a license amendment for the t:slim X2™ insulin pump with Control-IQ+™ automated insulin delivery (AID)…
10 Nov 2026 Yahoo Finance TNDM Q3 2026 deep dive: business model transition, product launches, and leadership change
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 13.8% year on year to $283.7 million. The company expects the full year’s revenue to be around $1.08 billion, close to analysts’ estimates. Its GAAP loss…
07 Nov 2026 Yahoo Finance Can Tandem Diabetes Care (TNDM) Justify Its Valuation As Q3 Earnings Beat And CEO Change Land?
Tandem Diabetes Care (TNDM) is back in focus after third quarter results showed higher sales, a much smaller net loss, reaffirmed full year revenue guidance, and a planned CEO transition to Jeannette Bankes. The latest Q3 update and the CEO transition have landed against a choppy backdrop for…
06 Nov 2026 Yahoo Finance What Tandem Diabetes Care (TNDM) Said on Its Q3 Earnings Call
Tandem Diabetes Care (NASDAQ:TNDM) reported 14% revenue growth in the third quarter of 2026, as higher pump shipments, pharmacy pricing and international sales helped lift gross margin. The company also announced a CEO transition and signaled that a slower-than-expected shift to pharmacy distributio…
06 Nov 2026 Yahoo Finance Tandem Diabetes Care names next CEO
Jeannette Bankes will take over the role from John Sheridan, who will retire at the end of the year after leading the company since 2019…
06 Nov 2026 Yahoo Finance Tandem Diabetes Care, Inc. Q3 2026 Earnings Call Summary
Moby summary of Tandem Diabetes Care, Inc.'s Q3 2026 earnings call…
06 Nov 2026 Yahoo Finance Tandem (TNDM) Q3 2026 Earnings Call Transcript
Sheridan steps down as CEO while Mobi Tubeless nears FDA clearance…
06 Nov 2026 Yahoo Finance Tandem Diabetes Care Inc (TNDM) Q3 2026 Earnings Call Highlights: Record Revenue and Pipeline ...
Tandem Diabetes Care Inc (TNDM) posts 14% revenue growth and record pump shipments while recalibrating 2027 outlook on slower pharmacy adoption and CEO transition.
06 Nov 2026 Yahoo Finance Earnings Beat Raises Fresh Questions For Tandem Diabetes Care Stock
Tandem Diabetes Care reported third quarter 2026 sales of US$283.69 million and a net loss of US$7.09 million, with earnings per share loss of US$0.10, and confirmed a CEO transition to Jeannette Bankes as John Sheridan prepares to retire. The combination of higher reported sales, reduced reported…
Papar semua

Persediaan Teknikal Sederhana

Susunan aliran
Kecerunan
Kemasukan –
Dagangan
Aliran menurun, tetapi purata bergeraknya telah mendatar.
Sokongan terdekat: 16.56 – 18.59 · paras kukuh · kerap diuji, mungkin pecah
Rintangan terdekat: 19.22 – 21.17 · paras kukuh

AI Analisis Teknikal

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda